Skip to main content

Exactech Agrees On Summary Judgment For AcuMatch Hip Implant

Exactech Agrees On Summary Judgment For AcuMatch Hip Implant

Exactech Agrees On Summary Judgment For AcuMatch Hip Implant

Introduction

In a motion filed on August 14 in the Eastern District of Tennessee, Exactech Inc. agreed on a summary judgment in a plaintiff's case involving allegations regarding the company's AcuMatch hip implant. The move was taken considering the company's declaration that there was no written warranty that the device had a shelf life of more than 15 years; hence, the case could be barred under Texas law. The manufacturer challenges the evidence and testimony, stating that neither the plaintiff nor the performing surgeon counted on the written warranty details for the hip implant.

Similar allegations are piling up in the federal courts across the U.S. against other hip implant manufacturers including Zimmer, Biomet, and Stryker. Zimmer has settled many of the lawsuits between 2016 and 2017, but as of August 2018, about 131 cases linked to complications due to Zimmer Durom Hip Cup Implant, are still pending in the Multidistrict Litigation ( MDL No. 2158 (In Re: Zimmer Durom Hip Cup Products Liability Litigation), which is overlooked by Judge Susan D. Wigenton in the U.S. District for New Jersey.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.